|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2006-8-10
|
|
pubmed:abstractText |
Gastric cancer and its premalignant gastric lesion, intestinal metaplasia (IM), frequently express cyclooxygenase-2 (COX-2) at high levels. We tested whether long-term use of specific COX-2 inhibitors regress gastric IM.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4766-72
|
|
pubmed:meshHeading |
pubmed-meshheading:16899628-Adenocarcinoma,
pubmed-meshheading:16899628-Antineoplastic Agents,
pubmed-meshheading:16899628-Double-Blind Method,
pubmed-meshheading:16899628-Drug Administration Schedule,
pubmed-meshheading:16899628-Follow-Up Studies,
pubmed-meshheading:16899628-Gastrointestinal Neoplasms,
pubmed-meshheading:16899628-Humans,
pubmed-meshheading:16899628-Lactones,
pubmed-meshheading:16899628-Male,
pubmed-meshheading:16899628-Metaplasia,
pubmed-meshheading:16899628-Middle Aged,
pubmed-meshheading:16899628-Neoplasm Staging,
pubmed-meshheading:16899628-Placebos,
pubmed-meshheading:16899628-Prospective Studies,
pubmed-meshheading:16899628-Sulfones,
pubmed-meshheading:16899628-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial.
|
|
pubmed:affiliation |
Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. wkleung@cuhk.edu.hk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
